Pharsight

INNATE PHARMA SAS patents facing oppositions

Top patents of INNATE PHARMA SAS facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3405495B1 24 Feb, 2021 Neutralization of inhibitory pathways in lymphocytes Jan, 2037 1
EP3191517B1 04 Nov, 2020 Cross reactive siglec antibodies Sep, 2035 1